Minerva Biotechnologies Is A Clinical Stage Biopharmaceutical Company Based In Walthammassachusettsfounded In 1999The Company Focuses On Developing Cancer Immunotherapies And Stem Cell Therapeuticsspecifically Targeting Solid Tumors And Preventing Cancer Metastasis Minerva S Cancer Immunotherapy Efforts Include Muc1Targeted Car T Therapieswhich Aim To Treat Approximately 80Of Solid Tumorssuch As Those Found In Breastlungand Pancreatic Cancersthe Company Also Works On Preventing Cancer Spread By Targeting Critical Pathways For Tumor Growthin The Realm Of Stem Cell Therapeuticsminerva Explores Growth Factor Receptors To Support Regenerative Medicinecollaborating With Partners To Develop Therapies For Conditions Like Multiple Sclerosis Led By Drcynthia Bamdada Pioneer In Biochip Technologyminerva Is Committed To Advancing Its Clinical Programs Through Strategic Partnerships And Fundraising Effortsthe Company Has Raised Over $70 Million To Support Its Innovative Research In Oncology And Regenerative Medicine
No conferences found for this company.
| Company Name | Minerva Biotechnologies Corporation |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
